These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26335114)

  • 21. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
    Zhang YS; Li Q; He BS; Liu R; Li ZJ
    World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to: High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: utility or futility?
    Marmo R; Soncini M; Bucci C; Zullo A
    Dig Liver Dis; 2021 Mar; 53(3):389. PubMed ID: 33472768
    [No Abstract]   [Full Text] [Related]  

  • 23. Stress Ulcer Prophylaxis.
    Barletta JF; Bruno JJ; Buckley MS; Cook DJ
    Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
    Chang YW
    Korean J Gastroenterol; 2009 Feb; 53(2):126-8. PubMed ID: 19237840
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uses and abuses of acid-suppression therapy in children.
    Hassall E
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S8-9. PubMed ID: 22235449
    [No Abstract]   [Full Text] [Related]  

  • 29. Critical gastrointestinal bleeding at an inpatient rehabilitation center: incidence, risk factors, and the role of gastrointestinal prophylaxis.
    Faulk CE; Sandoval A; Draughon M; Moore D; Whitted T; Wilford R
    PM R; 2010 Dec; 2(12):1104-12. PubMed ID: 21145522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
    Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
    Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.
    Wu CK; Liang CM; Hsu CN; Hung TH; Yuan LT; Nguang SH; Wang JW; Tseng KL; Ku MK; Yang SC; Tai WC; Shih CW; Hsu PI; Wu DC; Chuah SK
    PLoS One; 2017; 12(1):e0169884. PubMed ID: 28118373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The short-term medical management of non-variceal upper gastrointestinal bleeding.
    Kovacs TO; Jensen DM
    Drugs; 2008; 68(15):2105-11. PubMed ID: 18840002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding.
    Yacyshyn BR; Thomson AB
    Dig Dis; 2000; 18(3):117-28. PubMed ID: 11279330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
    Huggins RM; Scates AC; Latour JK
    Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of H2 receptor antagonists for prevention of upper gastrointestinal bleeding during dual-antiplatelet therapy.
    Yasu T; Sato N; Kurokawa Y; Saito S; Shoji M
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):854-60. PubMed ID: 24040853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleeding in the upper part of the gastrointestinal tract due to stress ulcers.
    Carlson RW; Baker L; Andhavarapu S
    Am J Crit Care; 2008 Mar; 17(2):148-9. PubMed ID: 18310652
    [No Abstract]   [Full Text] [Related]  

  • 39. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
    Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
    Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic therapy for nonvariceal upper gastrointestinal bleeding.
    Wu JC; Sung JJ
    Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):671-9. PubMed ID: 21944417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.